Erratum: Rational design of potent domain antibody inhibitors of amyloid fibril assembly (Proceedings of the National Academy of Sciences of the United States of America (2012) 49:109 (19965-19970) DOI: 10.1073/pnas.1208797109);Rational design of potent domain antibody inhibitors of amyloid fibril assembly

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 49, 2012, Pages 19965-19970

  Ladiwala, Ali Reza A ^a   Bhattacharya, Moumita ^a   Perchiacca, Joseph M ^a   Cao, Ping ^b   Raleigh, Daniel P ^b   Abedini, Andisheh ^c   Schmidt, Ann Marie ^c   Varkey, Jobin ^d   Langen, Ralf ^d   Tessier, Peter M ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Beta amyloid; IAPP; Misfolding; Protein design

Indexed keywords

ALPHA SYNUCLEIN; AMYLIN; AMYLOID BETA PROTEIN; AMYLOID PROTEIN; GAMMABODY; MONOMER; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; FIBER; HUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN MOTIF; STOICHIOMETRY; VACCINATION;

EID: 84870607253     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1221819110     Document Type: Erratum

References (40)

1. Härd T, Lendel C (2012) Inhibition of amyloid formation. J Mol Biol 421(4-5):441-465.
2. Solomon B, Koppel R, Hanan E, Katzav T (1996) Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci USA 93(1):452-455.
3. Emadi S, et al. (2004) Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry 43(10):2871-2878.
4. Perchiacca JM, Ladiwala AR, Bhattacharya M, Tessier PM (2012) Structure-based design of conformation- and sequence-specific antibodies against amyloid β. Proc Natl Acad Sci USA 109(1):84-89.
5. Kayed R, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300(5618):486-489.
6. Kayed R, et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2:18.
7. O'Nuallain B, Wetzel R (2002) Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci USA 99(3):1485-1490.
8. Barthelemy PA, et al. (2008) Comprehensive analysis of the factors contributing to the stability and solubility of autonomous humanVHdomains.J BiolChem283(6):3639-3654.
9. Perchiacca JM, Ladiwala AR, Bhattacharya M, Tessier PM (2012) Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions. Protein Eng Des Sel 25(10):591-602.
10. Ladiwala AR, et al. (2012) Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J Biol Chem 287(29):24765-24773.
11. Ehrnhoefer DE, et al. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15(6):558-566.
12. Ladiwala AR, Dordick JS, Tessier PM (2011) Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J Biol Chem 286(5):3209-3218.
13. Mustafi SM, Garai K, Crick SL, Baban B, Frieden C (2010) Substoichiometric inhibition of Abeta(1-40) aggregation by a tandem Abeta(40-1-Gly8-1-40) peptide. Biochem Biophys Res Commun 397(3):509-512.
14. Evans CG, Wisén S, Gestwicki JE (2006) Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem 281(44):33182-33191.
15. Luk KC, Mills IP, Trojanowski JQ, Lee VM (2008) Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibitfibril assembly. Biochemistry 47(47):12614-12625.
16. Dedmon MM, Christodoulou J, Wilson MR, Dobson CM (2005) Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem 280(15):14733-14740.
17. Mannini B, et al. (2012) Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc Natl Acad Sci USA 109(31):12479-12484.
18. Johnson KH, O'Brien TD, Betsholtz C, Westermark P (1992) Islet amyloid polypeptide: Mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus. Lab Invest 66(5):522-535.
19. Duda JE, Lee VM, Trojanowski JQ (2000) Neuropathology of synuclein aggregates. J Neurosci Res 61(2):121-127.
20. Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L (2004) A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342(1):345-353.
21. Conchillo-Solé O, et al. (2007) AGGRESCAN: A server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8:65.
22. Thompson MJ, et al. (2006) The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA 103(11):4074-4078.
23. Trovato A, Seno F, Tosatto SC (2007) The PASTA server for protein aggregation prediction. Protein Eng Des Sel 20(10):521-523.
24. Maurer-Stroh S, et al. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods 7(3):237-242.
25. Ghanta J, Shen CL, Kiessling LL, Murphy RM (1996) A strategy for designing inhibitors of beta-amyloid toxicity. J Biol Chem 271(47):29525-29528.
26. Soto C, et al. (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nat Med 4(7):822-826.
27. Sievers SA, et al. (2011) Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475(7354):96-100.
28. Tjernberg LO, et al. (1996) Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 271(15):8545-8548.
29. Takahashi T, Mihara H (2008) Peptide and protein mimetics inhibiting amyloid betapeptide aggregation. Acc Chem Res 41(10):1309-1318.
30. Scrocchi LA, et al. (2002) Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J Mol Biol 318(3):697-706.
31. Kapurniotu A, Schmauder A, Tenidis K (2002) Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J Mol Biol 315(3):339-350.
32. Scheidt HA, Morgado I, Rothemund S, Huster D, Fändrich M (2011) Solid-state NMR spectroscopic investigation of Aβ protofibrils: Implication of a β-sheet remodeling upon maturation into terminal amyloid fibrils. Angew Chem Int Ed Engl 50(12):2837-2840.
33. Kheterpal I, Chen M, Cook KD, Wetzel R (2006) Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange - mass spectrometry with on-line proteolytic fragmentation. J Mol Biol 361(4):785-795.
34. Habicht G, et al. (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci USA 104(49):19232-19237.
35. Adekar SP, et al. (2010) Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains. J Biol Chem 285(2):1066-1074.
36. O'Nuallain B, Hrncic R, Wall JS, Weiss DT, Solomon A (2006) Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera. J Immunol 176(11):7071-7078.
37. Yoshihara T, et al. (2008) Immunoreactivity of phage library-derived human singlechain antibodies to amyloid beta conformers in vitro. J Biochem 143(4):475-486.
38. Frenkel D, Balass M, Katchalski-Katzir E, Solomon B (1999) High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation. J Neuroimmunol 95(1-2):136-142.
39. Abedini A, Raleigh DP (2005) Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide. Org Lett 7(4):693-696.
40. Chen M, Margittai M, Chen J, Langen R (2007) Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J Biol Chem 282(34):24970-24979.